Table 2 Five-fold cross validation performance of the proposed method using post-ablation SPECT/CT.
Region | Five-fold | Pre (%) | Rec (%) | F1-score (%) | DSC (%) |
|---|---|---|---|---|---|
mLN | Fold 1 | 87.0 | 88.0 | 87.5 | 86.7 |
Fold 2 | 82.9 | 83.2 | 83.0 | 80.2 | |
Fold 3 | 90.1 | 69.7 | 78.6 | 79.3 | |
Fold 4 | 90.0 | 70.2 | 78.4 | 77.0 | |
Fold 5 | 72.0 | 70.4 | 71.1 | 71.5 | |
Remnant tissue | Fold 1 | 97.0 | 77.5 | 86.2 | 87.1 |
Fold 2 | 88.2 | 89.0 | 88.5 | 90.0 | |
Fold 3 | 98.3 | 81.0 | 88.8 | 88.0 | |
Fold 4 | 97.0 | 72.8 | 83.2 | 85.7 | |
Fold 5 | 98.0 | 79.0 | 87.5 | 88.0 | |
Background | Fold 1 | 96.0 | 94.3 | 95.1 | 97.0 |
Fold 2 | 99.5 | 100.0 | 99.7 | 99.3 | |
Fold 3 | 100.0 | 99.4 | 99.7 | 99.7 | |
Fold 4 | 99.0 | 99.2 | 99.1 | 99.0 | |
Fold 5 | 100.0 | 100.0 | 100.0 | 99.9 | |
Overall | Fold 1 | 93.3 | 85.1 | 88.9 | 88.1 |
Fold 2 | 90.9 | 90.7 | 90.8 | 90.5 | |
Fold 3 | 96.1 | 83.4 | 89.0 | 89.0 | |
Fold 4 | 92.3 | 82.1 | 86.6 | 87.2 | |
Fold 5 | 92.3 | 83.1 | 87.3 | 87.7 |
